SAKK 77/09: A phase I open label/Phase II randomized, double-blind, multicenter study investigating the combination of RAD001 and transArterial ChemoEmbolisation (TACE) with doxorubicin in patients with hepatocellular carcinoma eligible for TACE

A randomized open label study evaluating the efficacy of continuous telbivudine versus lamivudine in patients with HBeAg-negative Chronic Hepatitis B who had previously achieved an undetectable viral load during 24 weeks of telbivudine therapy